Asparaginase clinical trials
Also written Elspar and Colaspase.
How each study uses Asparaginase is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Asparaginase studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 10 Jan 1978 · ELSPAR · BLA 101063 (FDA, Drugs@FDA)
- European Union
- 14 Jan 2016 · Spectrila · EMEA/H/C/002661 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
44 studies that test it; most in 2002 (5)
| Year | Studies |
|---|---|
| 1990 | 1 |
| 1993 | 1 |
| 1995 | 1 |
| 1996 | 4 |
| 1997 | 1 |
| 1998 | 3 |
| 1999 | 3 |
| 2000 | 3 |
| 2002 | 5 |
| 2003 | 3 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2023 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 1 · Other 43
Children's Oncology Group (9) · St. Jude Children's Research Hospital (7) · National Cancer Institute (NCI) (5) · Dana-Farber Cancer Institute (2) · Goethe University (2) · SWOG Cancer Research Network (2) · Fudan University (2) · The University of Hong Kong (2)
Often tested with
Tested in the same studies.
Dexamethasone (26) · Methotrexate (25) · Cyclophosphamide (22) · Vincristine (22) · Mercaptopurine (21) · Daunorubicin (20) · Cytarabine (20) · Etoposide (19)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Tested against it · 2 phase 3 studies under way
Asparaginase is the comparator. A study of two new drugs counts under both.
- 1Blinatumomab · National Cancer Institute (NCI)
- 1Cyclophosphamide · National Cancer Institute (NCI)
- 1Etoposide · National Cancer Institute (NCI)
- 1Leucovorin · National Cancer Institute (NCI)
- 1Mercaptopurine · National Cancer Institute (NCI)
- 1Pegaspargase · National Cancer Institute (NCI)
- 1Thioguanine · National Cancer Institute (NCI)
- 1Vincristine · National Cancer Institute (NCI)
Studies
Open first, then newest update. How each study uses Asparaginase is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 44
- Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in ChildrenRecruitingPhase 2Hee Young JuNCT06099366Written as induction: vincristine, L-asparaginase, dexamethasone, intrathecal Ara-C, intrathecal MethotrexateHow we know
- Efficacy of Acute Lymphoblastic Leukemia-Based Therapy in Treating Patients With Acute Leukemia of Ambiguous LineageRecruitingPhase 2Institute of Hematology & Blood Diseases Hospital, ChinaNCT04440267Written as L-AsparaginaseHow we know
- Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down SyndromeActive, not recruitingPhase 3Children's Oncology GroupNCT02521493Written as AsparaginaseHow we know
- Bortezomib and Sorafenib Tosylate in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedPhase 3National Cancer Institute (NCI)NCT01371981Written as AsparaginaseHow we know
- PK, PD, Safety and Immunogenicity of Spectrila in Adults With Acute B-cell Lymphoblastic LeukaemiaTerminatedPhase 2medac GmbHNCT03156790Written as Spectrila®How we know
- A Study in Adults With Untreated Acute Lymphoblastic LeukemiaCompletedPhase 2Dana-Farber Cancer InstituteNCT00136435Written as asparaginaseHow we know
- Compassionate Use of Asparaginase and Pembrolizumab Combination Theaapy for Nasopharyngeal CarcinomaCompletedNot applicableChang Gung Memorial HospitalNCT06676293Written as asparaginaseHow we know
- LSA4 Protocol for the Treatment of Advanced Pediatric and Adolescent Non-Hodgkins LymphomaCompletedPhase 2Memorial Sloan Kettering Cancer CenterNCT00610883Written as LSA4, Cyclophosphamide, Methotrexate, Daunomycin, L-asparaginase, BCNUHow we know
- German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedPhase 4Goethe UniversityNCT00198978Written as AsparaginaseHow we know
- German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)CompletedPhase 4Goethe UniversityNCT00198991Written as AsparaginaseHow we know
- Asparaginase Activity Monitoring (AAM) in Adult Patients With Acute Lymphoblastic Leukemia (ALL)TerminatedPhase 2Gruppo Italiano Malattie EMatologiche dell'AdultoNCT03668392Written as AsparaginaseHow we know
- Combination Chemotherapy in Treating Young Patients With Down Syndrome and Acute Myeloid Leukemia or Myelodysplastic SyndromesCompletedPhase 3Children's Oncology GroupNCT00369317Written as asparaginaseHow we know
- VP-16, Ifosfamide, Dexamethasone, L-asparaginase Chemotherapy in Patients With Extranodal Natural Killer T Cell Lymphoma (VIDL+ASCT)Status unknownPhase 2Samsung Medical CenterNCT02544425Written as L-asparaginaseHow we know
- Therapy for Newly Diagnosed Patients With Acute Lymphoblastic LeukemiaCompletedPhase 3St. Jude Children's Research HospitalNCT00137111Written as Doxorubicin, L-asparaginase, PEG-L-asparaginase, Erwinia asparaginaseHow we know
- Erwinia Asparaginase After Allergy to PEG-Asparaginase in Treating Young Patients With Acute Lymphoblastic LeukemiaCompletedNot applicableChildren's Oncology GroupNCT00537030Written as AsparaginaseHow we know
- Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaWithdrawnPhase 2University of WashingtonNCT02538926Written as AsparaginaseHow we know
- SIMPLE Chemotherapy for NK Lymphoma/LeukaemiaStatus unknownPhase 3The University of Hong KongNCT03623087Written as L-asparaginaseHow we know
- Combination Chemotherapy Including Cisplatin, Ifosfamide, Gemcitabine, L-asparaginase, Etoposide and Dexamethasone as Treatment of Newly Diagnosed and Relapsed/Refractory Peripheral T Cell LymphomasStatus unknownPhase 4The University of Hong KongNCT03071822Written as L-asparaginaseHow we know
- Therapy for Pediatric Relapsed or Refractory Acute Lymphoblastic LeukemiaCompletedPhase 2St. Jude Children's Research HospitalNCT00186875Written as L-asparaginase, erwinia asparaginaseHow we know
- Phase II Study of Clinical Activity of Pegaspargase in Women With Relapsed or Refractory Epithelial Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal CancerCompletedPhase 2National Cancer Institute (NCI)NCT01313078Written as Pegylated L-AsparaginaseHow we know
See all 44 studies that test Asparaginase →
Given beside what is tested · 29 — Asparaginase is usual care or a partner of the new treatment
- Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic LeukemiaRecruitingPhase 3Alliance for Clinical Trials in OncologyNCT03150693Written as Pegylated L-AsparaginaseHow we know
- Ma-Spore ALL 2020 StudyRecruitingPhase 2National University Hospital, SingaporeNCT06336395Written as L-AsparaginaseHow we know
- PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic LymphomaActive, not recruitingPhase 1/2Therapeutic Advances in Childhood Leukemia ConsortiumNCT03817320Written as AsparaginaseHow we know
- ALL Adult Consortium Trial: Adult ALL TrialCompletedPhase 2Dana-Farber Cancer InstituteNCT00476190Written as E. coli AsparaginaseHow we know
- Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedPhase 3Children's Oncology GroupNCT00557193Written as AsparaginaseHow we know
- Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic LeukemiaCompletedPhase 3Children's Oncology GroupNCT00381680Written as asparaginaseHow we know
- Stem Cell Transplantation Compared With Standard Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia in First RemissionCompletedPhase 3Eastern Cooperative Oncology GroupNCT00002514Written as asparaginaseHow we know
- Alemtuzumab and Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic LeukemiaCompletedPhase 1/2National Cancer Institute (NCI)NCT00061945Written as asparaginaseHow we know
- Combination Chemotherapy With or Without Gemtuzumab in Treating Young Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedPhase 3Children's Oncology GroupNCT00372593Written as asparaginaseHow we know
- Nivolumab in Combination With GDP/ L-asparaginase in NK/ T-cell LymphomaWithdrawnPhase 1National Cancer Centre, SingaporeNCT04230330Written as IV L-asparaginaseHow we know
- Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedPhase 2/3National Cancer Institute (NCI)NCT00720109Written as AsparaginaseHow we know
- Pethema LAL-RI/2008: Treatment for Patients With Standard Risk Acute Lymphoblastic LeukemiaCompletedPhase 4PETHEMA FoundationNCT02036489Written as L-asparaginaseHow we know
- Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic LymphomaCompletedPhase 3Children's Oncology GroupNCT00004228Written as asparaginaseHow we know
- Chemoimmunotherapy With Epratuzumab in Relapsed Acute Lymphoblastic Leukemia (ALL)CompletedPhase 1/2Children's Oncology GroupNCT00098839Written as L-asparaginaseHow we know
- Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedPhase 3Children's Oncology GroupNCT00002744Written as asparaginaseHow we know
- Bortezomib and Combination Chemotherapy in Treating Young Patients With Relapsed Acute Lymphoblastic Leukemia or Lymphoblastic LymphomaCompletedPhase 2National Cancer Institute (NCI)NCT00873093Written as L-asparaginaseHow we know
- Malaysia-Singapore Acute Lymphoblastic Leukemia 2010 StudyStatus unknownPhase 4National University Hospital, SingaporeNCT02894645Written as L-AsparaginaseHow we know
- Combination Chemotherapy in Treating Patients With Untreated Acute Lymphoblastic LeukemiaCompletedPhase 2Alliance for Clinical Trials in OncologyNCT00003700Written as asparaginaseHow we know
- Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid LeukemiaCompletedPhase 1Children's Oncology GroupNCT00004056Written as asparaginaseHow we know
- CINJALL: Treatment for Children With Acute Lymphocytic LeukemiaCompletedPhase 2Rutgers, The State University of New JerseyNCT00176462Written as L-asparaginaseHow we know
Showing 20 of 29.
As the comparator · 7 — what is tested is compared with Asparaginase
- Comparing the Efficacy of VHAG and Traditional Chemotherapy Regimens in Newly Diagnosed ETP-ALLRecruitingPhase 3First Affiliated Hospital of Zhejiang UniversityNCT06361329Written as L-ASPHow we know
- Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic LeukemiaActive, not recruitingPhase 3National Cancer Institute (NCI)NCT02101853Written as AsparaginaseHow we know
- 05-001: Treatment of Acute Lymphoblastic Leukemia in ChildrenCompletedPhase 3Dana-Farber Cancer InstituteNCT00400946Written as asparaginaseHow we know
- Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic LymphomaCompletedPhase 3National Cancer Institute (NCI)NCT00408005Written as AsparaginaseHow we know
- GRASPA (Erythrocytes Encapsulating L-asparaginase) in Patients With Relapse of Acute Lymphoblastic LeukemiaCompletedPhase 2/3ERYtech PharmaNCT01518517Written as L-asparaginaseHow we know
- Childhood Acute Lymphoblastic Leukemia Treatment Protocol Moscow-Berlin 2008Status unknownNot applicableFederal Research Institute of Pediatric Hematology, Oncology and ImmunologyNCT01953770Written as E.coli L-asparaginaseHow we know
- Comparative Efficacy and Safety of Two Asparaginase Preparations in Children With Previously Untreated Acute Lymphoblastic LeukaemiaCompletedPhase 3medac GmbHNCT00784017Written as asparaginaseHow we know
Codes
What other systems call Asparaginase · ClinicalTrials.gg INT007027
- MeSH (NLM) D001215AsparaginaseOne source ClinicalTrials.gov
- UNII (FDA) G4FQ3CKY5RASPARAGINASEConfirmed FDA, Wikidata
- RxNorm 1156Confirmed FDA, Wikidata
- NCI Thesaurus C286AsparaginaseOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D001215 | Asparaginase | One source ClinicalTrials.gov |
| UNII (FDA) | G4FQ3CKY5R | ASPARAGINASE | Confirmed FDA, Wikidata |
| RxNorm | 1156 | — | Confirmed FDA, Wikidata |
| NCI Thesaurus | C286 | Asparaginase | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.